Aurobindo Pharma recalls pink Amlodipine/Olmesartan tablets due to discoloration
Aurobindo Pharma recalls 5mg/40mg Amlodipine and Olmesartan Medoxomil tablets that were pink instead of cream. This is a pharmacist-reported discoloration issue for prescription use.
Recall notice
Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).
Contact the company
What happened, in plain English
Aurobindo Pharma is recalling prescription 5mg/40mg Amlodipine and Olmesartan Medoxomil tablets that were reported to be pink instead of cream. This discoloration could indicate a manufacturing issue that might affect the medication's safety or effectiveness. Read more at govinfonow.com/recall/39399-aurobindo-pharma-recalls-pink-amlodipine-olmesartan-tablets-due-to-discoloration.
Source Summary by GovInfoNow · govinfonow.com/recall/39399-aurobindo-pharma-recalls-pink-amlodipine-olmesartan-tablets-due-to-discoloration · Updated October 5, 2026 · FDA enforcement record: FDA #D-0289-2019
Cite this page
“Aurobindo Pharma recalls pink Amlodipine/Olmesartan tablets due to discoloration.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39399-aurobindo-pharma-recalls-pink-amlodipine-olmesartan-tablets-due-to-discoloration. Based on FDA recall #D-0289-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0289-2019%22&limit=1).
Why it’s dangerous
The tablets were reported to be pink instead of the expected cream (peach) color by pharmacists. This discoloration could indicate a manufacturing issue that might affect the medication's safety or effectiveness, though the exact risk is not specified in the recall.
Who’s affected
Prescription patients who have the 30-count bottle of Amlodipine and Olmesartan Medoxomil tablets (5 mg/40 mg) with the lot number OWSA18002-A. Those who have the tablets and are taking them as prescribed are most at risk.
How to tell if you have this one
Check for the 30-count bottle labeled 'Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg' with lot number OWSA18002-A. The tablets should be cream (peach) color, not pink.
- Brand
Aurobindo Pharma- Category
Drug
What to do — step by step
Check Tablet Color
Look for pink tablets instead of the expected cream (peach) color.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Aurobindo Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0289-2019 (November 30, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0289-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.